CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,829,525 | -11.8% | 62,102 | -2.3% | 1.12% | -6.5% |
| Q2 2023 | $2,073,360 | -7.9% | 63,561 | -0.6% | 1.20% | -15.1% |
| Q1 2023 | $2,251,315 | -25.5% | 63,976 | -3.0% | 1.41% | -29.4% |
| Q4 2022 | $3,022,608 | -8.1% | 65,967 | -2.8% | 1.99% | -13.3% |
| Q3 2022 | $3,288,000 | +23.0% | 67,859 | -0.3% | 2.30% | +28.6% |
| Q2 2022 | $2,674,000 | +5.4% | 68,062 | -1.3% | 1.79% | +29.7% |
| Q1 2022 | $2,538,000 | -19.4% | 68,962 | -0.1% | 1.38% | -11.4% |
| Q4 2021 | $3,148,000 | +29.6% | 69,059 | +1.6% | 1.56% | +23.7% |
| Q3 2021 | $2,429,000 | +79.9% | 67,963 | -0.4% | 1.26% | +84.9% |
| Q2 2021 | $1,350,000 | -16.1% | 68,240 | -1.4% | 0.68% | -20.0% |
| Q1 2021 | $1,609,000 | +10.8% | 69,188 | -1.0% | 0.85% | +0.1% |
| Q4 2020 | $1,452,000 | -5.7% | 69,855 | -1.8% | 0.85% | -22.8% |
| Q3 2020 | $1,540,000 | -8.2% | 71,124 | -0.1% | 1.10% | -15.8% |
| Q2 2020 | $1,678,000 | +98.8% | 71,209 | -0.5% | 1.31% | +54.7% |
| Q1 2020 | $844,000 | +46.8% | 71,550 | +32.0% | 0.84% | +112.8% |
| Q4 2019 | $575,000 | -10.4% | 54,216 | -3.9% | 0.40% | -17.5% |
| Q3 2019 | $642,000 | +0.8% | 56,442 | -0.3% | 0.48% | -3.4% |
| Q2 2019 | $637,000 | +16.9% | 56,599 | -16.0% | 0.50% | +12.4% |
| Q1 2019 | $545,000 | -5.1% | 67,352 | -25.8% | 0.44% | -16.6% |
| Q4 2018 | $574,000 | -42.4% | 90,783 | -10.2% | 0.53% | -23.7% |
| Q3 2018 | $996,000 | +15.3% | 101,091 | -2.9% | 0.70% | +13.5% |
| Q2 2018 | $864,000 | +14.0% | 104,096 | -1.2% | 0.61% | +10.6% |
| Q1 2018 | $758,000 | -13.2% | 105,324 | -1.7% | 0.55% | -11.2% |
| Q4 2017 | $873,000 | -45.5% | 107,139 | -3.1% | 0.62% | -44.6% |
| Q3 2017 | $1,602,000 | +15.8% | 110,512 | -3.3% | 1.13% | +12.5% |
| Q2 2017 | $1,383,000 | -8.9% | 114,262 | -3.3% | 1.00% | -11.9% |
| Q1 2017 | $1,518,000 | +2.9% | 118,102 | -2.7% | 1.14% | +5.5% |
| Q4 2016 | $1,475,000 | +20.3% | 121,360 | -9.1% | 1.08% | +14.3% |
| Q3 2016 | $1,226,000 | -14.5% | 133,509 | -11.6% | 0.94% | -12.3% |
| Q2 2016 | $1,434,000 | +16.7% | 151,106 | -13.3% | 1.07% | +33.4% |
| Q1 2016 | $1,229,000 | -53.0% | 174,305 | -30.3% | 0.80% | -25.4% |
| Q4 2015 | $2,615,000 | +14.6% | 250,005 | -26.7% | 1.08% | +28.8% |
| Q3 2015 | $2,282,000 | -22.0% | 341,116 | -21.6% | 0.84% | +24.5% |
| Q2 2015 | $2,925,000 | -29.4% | 435,202 | -28.8% | 0.67% | -12.3% |
| Q1 2015 | $4,142,000 | -13.4% | 610,933 | +2.3% | 0.77% | -12.1% |
| Q4 2014 | $4,785,000 | +127.9% | 597,319 | +0.1% | 0.87% | +129.7% |
| Q3 2014 | $2,100,000 | -21.3% | 596,583 | +6.8% | 0.38% | -10.6% |
| Q2 2014 | $2,670,000 | -48.2% | 558,536 | +2.9% | 0.42% | -43.3% |
| Q1 2014 | $5,159,000 | +44.5% | 543,022 | -1.2% | 0.75% | +50.7% |
| Q4 2013 | $3,571,000 | -5.3% | 549,426 | +10.3% | 0.50% | -16.0% |
| Q3 2013 | $3,770,000 | +21.5% | 498,012 | +85.7% | 0.59% | +7.4% |
| Q2 2013 | $3,102,000 | – | 268,128 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |